These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 1431138)
1. Plasminogen activator in granulocyte-macrophage-CSF transgenic mice. Elliott MJ; Faulkner-Jones BE; Stanton H; Hamilton JA; Metcalf D J Immunol; 1992 Dec; 149(11):3678-81. PubMed ID: 1431138 [TBL] [Abstract][Full Text] [Related]
2. Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice. Elliott MJ; Strasser A; Metcalf D J Immunol; 1991 Nov; 147(9):2957-63. PubMed ID: 1655901 [TBL] [Abstract][Full Text] [Related]
3. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related]
4. Regulation of plasminogen activator activity in arthritic joints. Hamilton JA; Hart PH; Leizer T; Vitti GF; Campbell IK J Rheumatol Suppl; 1991 Feb; 27():106-9. PubMed ID: 1902874 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells. Saishoji T; Higashi T; Ikeda K; Sano H; Jinnouchi Y; Ogawa M; Horiuchi S Biochem Biophys Res Commun; 1995 Dec; 217(1):278-85. PubMed ID: 8526923 [TBL] [Abstract][Full Text] [Related]
7. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation. Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
9. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691 [TBL] [Abstract][Full Text] [Related]
10. Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells. Marutsuka K; Suzumiya J; Kataoka H; Komada N; Koono M; Sumiyoshi A Invasion Metastasis; 1991; 11(4):181-91. PubMed ID: 1765431 [TBL] [Abstract][Full Text] [Related]
11. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. Gross TJ; Sitrin RG J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes. Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206 [TBL] [Abstract][Full Text] [Related]
13. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [TBL] [Abstract][Full Text] [Related]
14. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines. Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839 [TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa. Berk RS; Katar M; Dong Z; Day DE Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061 [TBL] [Abstract][Full Text] [Related]
17. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony-stimulating factors and other agents. Hamilton JA; Vairo G; Knight KR; Cocks BG Blood; 1991 Feb; 77(3):616-27. PubMed ID: 1846764 [TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Chambers SK; Wang Y; Gertz RE; Kacinski BM Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368 [TBL] [Abstract][Full Text] [Related]
19. Regulation of urokinase plasminogen activator gene transcription in the RAW264 murine macrophage cell line by macrophage colony-stimulating factor (CSF-1) is dependent upon the level of cell-surface receptor. Fowles LF; Stacey KJ; Marks D; Hamilton JA; Hume DA Biochem J; 2000 Apr; 347 Pt 1(Pt 1):313-20. PubMed ID: 10727433 [TBL] [Abstract][Full Text] [Related]